The benefits of trastuzumab in the treatment of HER2+ breast cancer as a function of exposure time

Published: 11 February 2022| Version 4 | DOI: 10.17632/t3yb6fy69b.4
Contributors:
Felipe Andrés Cordero da Luz, Eduarda Marinho, Camila Nascimento, Lara Marques, Patrícia Delfino, Rafael Antonioli, Marcelo Silva, Rogério Araújo

Description

Dataset for the paper "The benefits of trastuzumab in the treatment of HER2+ breast cancer as a function of exposure time", DOI: 10.3332/ecancer.2022.1347

Files

Categories

Breast Cancer, Antineoplastic Agent, Trastuzumab, HER2-Positive Breast Cancer, Prognosis

Related Links

Article
https://ecancer.org/en/journal/article/1347-the-benefits-of-trastuzumab-in-the-treatment-of-her2-breast-cancer-as-a-function-of-exposure-time
is related to this dataset

Licence